Study to Evaluate the Impact of Obesity on Airway Inflammation and Mechanics in Asthmatics (ABI/BALA)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00615706 |
Recruitment Status
:
Completed
First Posted
: February 14, 2008
Last Update Posted
: September 23, 2008
|
Tracking Information | |||
---|---|---|---|
First Submitted Date | February 4, 2008 | ||
First Posted Date | February 14, 2008 | ||
Last Update Posted Date | September 23, 2008 | ||
Study Start Date | January 2005 | ||
Actual Primary Completion Date | September 2008 (Final data collection date for primary outcome measure) | ||
Current Primary Outcome Measures | Not Provided | ||
Original Primary Outcome Measures | Not Provided | ||
Change History | Complete list of historical versions of study NCT00615706 on ClinicalTrials.gov Archive Site | ||
Current Secondary Outcome Measures | Not Provided | ||
Original Secondary Outcome Measures | Not Provided | ||
Current Other Outcome Measures | Not Provided | ||
Original Other Outcome Measures | Not Provided | ||
Descriptive Information | |||
Brief Title | Study to Evaluate the Impact of Obesity on Airway Inflammation and Mechanics in Asthmatics | ||
Official Title | Not Provided | ||
Brief Summary | In the United States there has been a dramatic increase in the number of people who are obese and in the number of people who have asthma. Both are considered serious public health concerns. Several studies have shown that becoming obese or overweight can increase the risk of developing asthma or can make asthma symptoms more severe and difficult to control. How obesity affects asthma is not fully understood. This research study will examine whether obesity affects the amount of inflammation that is present in the lungs of people with asthma, and will also examine whether obesity leads to narrow and stiff airways. Participation in this study involves 2 visits in order to complete questionnaires, various pulmonary function tests, as well as the collection of blood, urine, and exhaled breath condensate specimens. This research study includes optional genetic and bronchoscopy substudies. |
||
Detailed Description | Not Provided | ||
Study Type | Observational | ||
Study Design | Time Perspective: Cross-Sectional | ||
Target Follow-Up Duration | Not Provided | ||
Biospecimen | Retention: Samples With DNA Description: Serum, urine, DNA, exhaled breath condensate. For substudy participants, bronchoalveolar lavage samples. |
||
Sampling Method | Non-Probability Sample | ||
Study Population | Asthmatics and healthy volunteers | ||
Condition | Asthma | ||
Intervention | Other: No intervention
no intervention |
||
Study Groups/Cohorts |
|
||
Publications * | Not Provided | ||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||
Recruitment Information | |||
Recruitment Status | Completed | ||
Estimated Enrollment |
300 | ||
Original Estimated Enrollment | Same as current | ||
Actual Study Completion Date | September 2008 | ||
Actual Primary Completion Date | September 2008 (Final data collection date for primary outcome measure) | ||
Eligibility Criteria | Inclusion Criteria:
Exclusion Criteria:
|
||
Sex/Gender |
|
||
Ages | 18 Years to 70 Years (Adult, Senior) | ||
Accepts Healthy Volunteers | Yes | ||
Contacts | Contact information is only displayed when the study is recruiting subjects | ||
Listed Location Countries | United States | ||
Removed Location Countries | |||
Administrative Information | |||
NCT Number | NCT00615706 | ||
Other Study ID Numbers | 345-2004 Emory IRB ID 345-2004 |
||
Has Data Monitoring Committee | No | ||
U.S. FDA-regulated Product | Not Provided | ||
IPD Sharing Statement | Not Provided | ||
Responsible Party | Fernando Holguin, MD, MPH, Emory University | ||
Study Sponsor | Emory University | ||
Collaborators | Critical Therapeutics | ||
Investigators | Not Provided | ||
PRS Account | Emory University | ||
Verification Date | September 2008 |